Addex Therapeutics Correlations

Stocks . USA . 
Stock . Addex Therapeutics
ADXN Stock  USD 0.71  0.0112  1.56%   
The correlation of Addex Therapeutics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Addex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Addex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Check out Trending Equities to better understand how to build diversified portfolios. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.
  
The ability to find closely correlated positions to Addex Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Addex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Addex Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Addex Therapeutics to buy it.

Moving together with Addex Stock

+0.75KAKineta Inc Symbol ChangePairCorr
+0.8YSYS Biopharma Report 2nd of June 2023 PairCorr
+0.68VACCVaccitech PLC ADR Fiscal Quarter End 30th of June 2023 PairCorr
+0.74DRMADermata Therapeutics Fiscal Quarter End 30th of June 2023 PairCorr
+0.77DTILPrecision BioSciences Fiscal Quarter End 30th of June 2023 PairCorr
+0.76VIGLVigil Neuroscience Fiscal Quarter End 30th of June 2023 PairCorr

Moving against Addex Stock

-0.72VKTXViking Therapeutics Fiscal Quarter End 30th of June 2023 PairCorr
-0.69DYAIDyadic International Fiscal Quarter End 30th of June 2023 PairCorr
-0.61VIRIVirios Therapeutics Llc Buyout TrendPairCorr
-0.43DVAXDynavax Technologies Fiscal Quarter End 30th of June 2023 PairCorr
-0.42VECTVectivBio Holding TrendingPairCorr

Related Correlations

DICE
EQ
DMAC
DNLI
VBIV
DICE
-0.460.270.63-0.5
DICE
EQ
-0.46-0.07-0.050.69
EQ
DMAC
0.27-0.070.73-0.19
DMAC
DNLI
0.63-0.050.73-0.28
DNLI
VBIV
-0.50.69-0.19-0.28
VBIV
DICE
EQ
DMAC
DNLI
VBIV
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

The Correlation Coefficient is a useful tool to identify correlated or non-correlated securities, which is essential in developing a diversified portfolio. It tells us the relationship between two positions you have in your portfolio or considering acquiring. Over a given time period, the two securities movetogether when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
DNLI
+ 0.73
DMAC
VBIV
+ 0.69
EQ
DNLI
+ 0.63
DICE
DMAC
+ 0.27
DICE
  
High negative correlations   
VBIV
- 0.5
DICE
EQ
- 0.46
DICE
VBIV
- 0.28
DNLI
VBIV
- 0.19
DMAC
DMAC
- 0.07
EQ
DNLI
- 0.05
EQ

Risk-Adjusted Indicators

Nowadays, there is a big difference between Addex Stock performing well and Addex Therapeutics company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Addex Therapeutics' multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation		Jensen
Alpha		Sortino
Ratio		Treynor
Ratio		Semi
Deviation		Information
Ratio		Expected
Shortfall		Potential
Upside		Value
At Risk		Maximum
Drawdown
DICE 2.74  0.26  0.07  0.15  3.34  0.07 (3.03)  6.80 (7.73)  15.55 
EQ 4.05 (0.32)  0.00 (0.19)  0.00 (0.06)  0.00  8.93 (8.82)  31.58 
DMAC 3.87  0.95  0.23  0.51  3.49  0.15 (4.96)  6.64 (5.81)  33.89 
DNLI 2.27  0.29  0.08  0.16  2.97  0.08 (2.36)  4.05 (5.11)  23.02 
VBIV 6.46 (1.62)  0.00 (0.52)  0.00 (0.18)  0.00  12.30 (11.54)  59.79 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Addex Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Piotroski F Score Now

   

Piotroski F Score

Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
All  Next Launch Module

Addex Therapeutics Corporate Management

Elected by the shareholders, the Addex Therapeutics' board of directors comprises two types of representatives: Addex Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Addex. The board's role is to monitor Addex Therapeutics' management team and ensure that shareholders' interests are well served. Addex Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Addex Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

Already Invested in Addex Therapeutics?

The danger of trading Addex Therapeutics is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Addex Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Addex Therapeutics. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Addex Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Addex Stock analysis

When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Is Addex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.41) 
Revenue Per Share
0.192
Quarterly Revenue Growth
0.493
Return On Assets
(0.83) 
Return On Equity
(1.90) 
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. Check out Trending Equities to better understand how to build diversified portfolios. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2023 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY